Healthcare Services

Global Adrenal Cancer Diagnostics Market Global Report 2026 Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Adrenal Cancer Diagnostics Market Across 2026–2030?

The adrenal cancer diagnostics market size has demonstrated strong growth in recent years. It is anticipated to increase from $148.54 billion in 2025 to $157.36 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.9%. The market’s past growth can be linked to the limited availability of high-resolution imaging modalities, an increasing occurrence of adrenal tumors, heightened awareness about adrenal cancer, the reliance on conventional biopsy techniques, and the expansion of hospital infrastructure.

The adrenal cancer diagnostics market is projected to experience substantial expansion over the next few years. This market is anticipated to reach a valuation of $206.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth over the projected period include advancements in contrast-enhanced imaging technologies, the development of targeted therapies for adrenal cancer, increased adoption of PET-CT combination scans, the establishment of more specialized cancer centers, and greater government investment in cancer diagnostics. Key trends anticipated during the forecast period involve a growing preference for sophisticated imaging methods for adrenal cancer, a rise in the application of minimally invasive biopsy techniques, an increase in targeted cancer therapy uses, the broadening of multidisciplinary cancer diagnostic facilities, and a heightened emphasis on prompt diagnosis and individualized patient care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp

What Drivers Are Shaping The Future Growth Of The Adrenal Cancer Diagnostics Market?

The escalating prevalence of cigarette smoking is anticipated to propel the adrenal cancer diagnostics market’s expansion moving forward. Cigarette smoking is defined as the act of inhaling and exhaling the fumes from burning tobacco, which contains nicotine, an addictive alkaloid known for its stimulating and tranquilizing psychoactive effects. This practice has been associated with an elevated risk of developing adrenal cancer, including both adrenal adenomas and adrenocortical carcinomas. The carcinogens present in tobacco smoke are capable of damaging the DNA within adrenal cells, leading to mutations that can instigate cancer. For instance, in August 2024, Statistics Canada, a Canada-based government agency, reported that Canadian manufacturers produced 1.2 billion cigarettes in July 2024. This figure marked a 4.3% increase from June 2024 and a 2.3% rise compared to July 2023. Thus, the increasing cigarette smoking is driving the growth of the adrenal cancer diagnostics market.

What Segmentation Levels Are Considered In The Adrenal Cancer Diagnostics Market?

The adrenal cancer diagnostics market covered in this report is segmented –

1) By Test: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Positron Emission Tomography (PET) Scan, Biopsy

2) By Tumor Type: Pheochromocytoma, Adrenal Cortical Carcinoma, Other Tumor Types

3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI, Functional MRI

2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT, Abdomen And Pelvis CT Scans

3) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans, Standalone PET Scans

4) By Biopsy: Fine Needle Aspiration Biopsy (FNA), Core Needle Biopsy, Surgical Biopsy

What Trends Are Projected To Affect The Adrenal Cancer Diagnostics Market?

Major companies operating in the adrenal cancer diagnostics market are pursuing innovative projects involving advanced collaboration models, such as the CancerX Startup Accelerator, to boost digital advancements in cancer care. This Accelerator is designed to offer promising startups mentorship, training, and direct access to crucial entities in the healthcare industry, including providers and pharmaceutical companies. For example, in November 2023, CanceRx, LLC, a US-based public-private partnership focused on accelerating cancer innovation, announced the initiation of this program at the Future of Cancer Care Summit in Tampa, Florida. The program intends to select its first cohort of approximately 15 to 20 companies starting in March 2024, with a focus on vital themes such as clinical research, screening, diagnosis, and treatment. This effort is expected to substantially progress the aims of the Cancer Moonshot initiative by addressing unfulfilled needs in cancer care and encouraging the development of effective digital health tools in oncology.

Which Leading Firms Are Contributing To The Growth Of The Adrenal Cancer Diagnostics Market?

Major companies operating in the adrenal cancer diagnostics market are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc.

Read the full adrenal cancer diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report

Which Geographic Regions Are Influencing Demand In The Adrenal Cancer Diagnostics Market?

North America was the largest region in the adrenal cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Adrenal Cancer Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13242&type=smp

Browse Through More Reports Similar to the Global Adrenal Cancer Diagnostics Market 2026, By The Business Research Company

cancer diagnostics global market report

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

skin cancer diagnostics global market report

https://www.thebusinessresearchcompany.com/report/skin-cancer-diagnostics-global-market-report

breast cancer diagnostics global market report

https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795